Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. News
  4. >
  5. 17 Stocks to Invest in for the 'Nuclear Revival'

17 Stocks to Invest in for the 'Nuclear Revival'

Written by Emily J. Thompson, Senior Investment Analyst
stocks logo
EMR.N+0.55%
stocks logo
UUUU.A-4.35%
Source: Barron's
Updated: Nov 17 2025
0mins
AI Stock Picker
AI Stock Picker
Source: Barron's
  • Nuclear Energy Renaissance: Brokerage firm Mizuho reports that nuclear energy is experiencing a resurgence, indicating a positive trend in the sector.
  • Investment Opportunities: This revival in nuclear energy presents new opportunities for investors looking to capitalize on the growing interest in this energy source.
stocks logo
EMR.N
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
no data image
No Data
Powered By
Intellectia
Analyst Views on EMR
Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 146.50 USD with a low forecast of 115.00 USD and a high forecast of 165.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 146.50 USD with a low forecast of 115.00 USD and a high forecast of 165.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 136.640
sliders
Low
115.00
Averages
146.50
High
165.00
Current: 136.640
sliders
Low
115.00
Averages
146.50
High
165.00
JPMorgan
Neutral
maintain
$151 -> $150
2025-11-10
Reason
JPMorgan
Price Target
$151 -> $150
2025-11-10
maintain
Neutral
Reason
JPMorgan lowered the firm's price target on Emerson to $150 from $151 and keeps a Neutral rating on the shares. The firm updated the company's model post the fiscal Q4 report.
Baird
Neutral
downgrade
$146 -> $143
2025-11-06
Reason
Baird
Price Target
$146 -> $143
2025-11-06
downgrade
Neutral
Reason
Baird lowered the firm's price target on Emerson to $143 from $146 and keeps a Neutral rating on the shares. The firm updated its model following results whic introduced moving pieces to its 2026 guidance but the underlying dynamics are stable and healthy.
RBC Capital
Outperform
maintain
$154 -> $155
2025-10-16
Reason
RBC Capital
Price Target
$154 -> $155
2025-10-16
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Emerson to $155 from $154 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 earnings in Industrials space. Multiple multi-year sector drivers - like electrification, reshoring, and datacenter/AI - and a Fed ease cycle should fuel continued mid-cycle growth and strong earnings visibility, while tariffs remain a fluid but manageable headwind for now, the analyst tells investors in a research note. Datacenter remains the strongest vertical in the sector and muni water the steadiest, while residential construction, HVAC, and chemicals are the weakest end markets, the firm added.
JPMorgan
Neutral
maintain
$135 -> $151
2025-10-15
Reason
JPMorgan
Price Target
$135 -> $151
2025-10-15
maintain
Neutral
Reason
JPMorgan raised the firm's price target on Emerson to $151 from $135 and keeps a Neutral rating on the shares as part of a Q3 earnings preview for the electrical equipment and multi-industry sector. The firm is a "bit more cautious" in the near term on the group but says valuation setup "is now at least more attractive." JPMorgan is "leaning more towards value plays with negative positioning" into the quarter.
See All Ratings
Financial AI Agent
Financial AI Agent
About EMR
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Top News

SpaceX Targets $800 Billion Valuation in Secondary Sale

06 Dec 25
news image

U.S. Consumer Sentiment Slightly Improves in December

06 Dec 25
news image

U.S. Consumer Spending Slows in September

06 Dec 25
news image

Netflix Acquires Warner Bros. Assets in $72B Deal

05 Dec 25
news image

Related Articles

Rigel Pharmaceuticals Updates R289 Clinical Data, Anticipates Phase 2 Dose Selection in 2026

22:42 PM
news image

MoonLake Immunotherapeutics Class Action Notice for Stock Purchasers

22:42 PM
news image

Sigh Up to Get Intellectia Insights

arrow icon

What qualifies a company as a Dividend Aristocrat in the S&P 500?

arrow icon

How do spin-offs inherit the dividend history of parent companies?

arrow icon

Will Emerson Electric continue to increase its dividends in the next decade?

arrow icon

Can new spin-offs maintain their inherited dividend aristocrat status long-term?

arrow icon

What factors make Emerson Electric a top dividend aristocrat stock pick?

People Also Watch

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free